Trilaciclib in Patients Receiving Sacituzumab Tirumotecan for EGFR-mutated, Advanced Non-Small Cell Lung Cancer (NSCLC)
Clinical trial NCT06992739 · RECRUITING
Trial details
- NCT number
- NCT06992739
- Sponsor
- The First Affiliated Hospital of Xiamen University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-08
- Primary completion
- 2027-03-01
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.